Atlas Trials

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

Clinical trial NCT02045017 · COMPLETED

Trial details

NCT number
NCT02045017
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-02-28
Primary completion
2017-01-27
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.